---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-005800"
form_type: "8-K"
ticker: "MANE"
cik: "0001827635"
company_name: "Veradermics, Inc"
filed_at: "2026-02-05T23:59:59+00:00"
generated_at: "2026-05-16T04:32:04.381200+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Veradermics files amended charter and bylaws after IPO closing on Feb 5, 2026

## Summary
- Authorized 200M shares of common stock and 25M shares of undesignated preferred stock.
- Eliminated prior preferred stock series and stockholder ability to act by written consent.
- Amended bylaws establish procedures for stockholder proposals, director nominations, and indemnification.

## SEC filing metadata
- accession: 0001628280-26-005800
- form_type: 8-K
- ticker: MANE
- cik: 0001827635
- company_name: Veradermics, Inc
- filed_at: 2026-02-05T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1827635/000162828026005800/0001628280-26-005800-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1827635/000162828026005800/veradermicsincclosing8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-005800
- JSON: https://secwatch.observer/filing/0001628280-26-005800.json
- Plain text: https://secwatch.observer/filing/0001628280-26-005800.txt

## Source-grounded claims
- claim_id: 2fbeed5f09310559892de47e269e0c92de8bbbdb
  claim: Veradermics, Inc: Amended and restated bylaws became effective upon IPO, establishing procedures for stockholder proposals and director nominations, modifying indemnification provisions, and conforming to the restated certificate (effective 2026-02-05).
  evidence_excerpt: the amended and restated bylaws of the Company (the “Amended and Restated Bylaws”), previously approved by the Company’s board of directors and stockholders, became effective.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1827635/000162828026005800/0001628280-26-005800-index.htm
- claim_id: df2910fc007de279e9c00a2217ddb3966720bc57
  claim: Veradermics, Inc: Fifth restated certificate of incorporation filed upon IPO, increasing authorized common stock to 200M shares, authorizing 25M preferred shares, eliminating prior preferred series references, and eliminating stockholder action by written consent (effective 2026-02-05).
  evidence_excerpt: the Company filed a fifth restated certificate of incorporation (the “Restated Certificate”) with the Secretary of State of the State of Delaware, which became effective upon filing.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1827635/000162828026005800/0001628280-26-005800-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.